183 related articles for article (PubMed ID: 26531698)
41. CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis.
van Veen T; Crusius JB; van Winsen L; Xia B; Barkhof F; Salvador Peña A; Polman CH; Uitdehaag BM
J Neuroimmunol; 2003 Jul; 140(1-2):188-93. PubMed ID: 12864988
[TBL] [Abstract][Full Text] [Related]
42. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.
Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V
Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760
[TBL] [Abstract][Full Text] [Related]
43. Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects.
de Almeida ER; Petzl-Erler ML
Int J Immunogenet; 2013 Jun; 40(3):178-85. PubMed ID: 22928528
[TBL] [Abstract][Full Text] [Related]
44. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
[TBL] [Abstract][Full Text] [Related]
45. Pemphigus vulgaris and pemphigus foliaceus determined by CD86 and CTLA4 polymorphisms.
Tanasilovic S; Popadic S; Medenica L; Popadic D
Clin Dermatol; 2017; 35(2):236-241. PubMed ID: 28274366
[TBL] [Abstract][Full Text] [Related]
46. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
48. Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis.
Handa T; Nagai S; Ito I; Tabuena R; Shigematsu M; Hamada K; Kitaichi M; Izumi T; Aoyama T; Toguchida J; Mishima M
Respiration; 2005; 72(3):243-8. PubMed ID: 15942292
[TBL] [Abstract][Full Text] [Related]
49. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma.
Chen YQ; Shi HZ
Allergy; 2006 Jan; 61(1):15-26. PubMed ID: 16364152
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
[TBL] [Abstract][Full Text] [Related]
51. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
Gunesacar R; Erken E; Dinkci S
Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
[TBL] [Abstract][Full Text] [Related]
52. T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development.
Ewing MM; Karper JC; Abdul S; de Jong RC; Peters HA; de Vries MR; Redeker A; Kuiper J; Toes RE; Arens R; Jukema JW; Quax PH
Int J Cardiol; 2013 Oct; 168(3):1965-74. PubMed ID: 23351788
[TBL] [Abstract][Full Text] [Related]
53. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
[TBL] [Abstract][Full Text] [Related]
54. Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathy.
Pawlowski P; Wawrusiewicz-Kurylonek N; Eckstein A; Reszec J; Luczynski W; Johnson K; Kretowski A; Bakunowicz-Lazarczyk A; Gorska M; Szamatowicz J; Chyczewski L; Mysliwiec J
Mediators Inflamm; 2015; 2015():340934. PubMed ID: 25653477
[TBL] [Abstract][Full Text] [Related]
55. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
Tomer Y; Greenberg DA; Barbesino G; Concepcion E; Davies TF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
[TBL] [Abstract][Full Text] [Related]
56. Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population.
Abdollah Zadeh R; Jalilian N; Sahraian MA; Kasraian Z; Noori-Daloii MR
Neurol Res; 2017 Mar; 39(3):217-222. PubMed ID: 28079472
[TBL] [Abstract][Full Text] [Related]
57. Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia.
Ramzi M; Arandi N; Saadi MI; Yaghobi R; Geramizadeh B
Exp Clin Transplant; 2020 Nov; 18(6):719-724. PubMed ID: 29697355
[TBL] [Abstract][Full Text] [Related]
58. The Association Between
Liu W; Yang Z; Chen Y; Yang H; Wan X; Zhou X; Liu R; Zhang Y
Front Med (Lausanne); 2021; 8():598076. PubMed ID: 33604347
[No Abstract] [Full Text] [Related]
59. The Influence of Genetic Variations in the
Karabon L; Markiewicz M; Chrobot K; Dzierzak-Mietla M; Pawlak-Adamska E; Partyka A; Koclega A; Kyrcz-Krzemien S; Frydecka I
J Immunol Res; 2018; 2018():3826989. PubMed ID: 29577049
[TBL] [Abstract][Full Text] [Related]
60. Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Immunol Invest; 2019 Aug; 48(6):659-671. PubMed ID: 31094250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
